Strategic partnerships Lumos is actively pursuing collaborations with diagnostic and healthcare players, including recent activity with Micro-Pak for contract manufacturing and with Mproassociates for US expansion, signaling openness to channel and alliance-based sales opportunities.

US expansion Recent partnerships and financing indicate a push into the US market, presenting a clear target for sales acceleration of POC tests and reader platforms through localized distribution, regulatory navigation support, and potential OEM opportunities.

POC portfolio Lumos develops and commercializes Lumos-branded POC tests for infectious and inflammatory diseases, suggesting cross-sell potential to healthcare providers seeking rapid diagnostic solutions and to labs requiring turnkey assay development and manufacturing.

Digital reader Proprietary digital reader platforms accompany Lumos tests, enabling value-added data capture and analytics offerings that can be bundled with training, support, and service contracts to drive recurring revenue.

Clinical collaboration Existing collaborations in liver health monitoring and pre-term birth assays with Burnet and Hologic imply opportunities to expand into maternal-fetal and liver disease monitoring segments, as well as co-development deals with major diagnostic players.